Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q96LJ7
UPID:
DHRS1_HUMAN
Alternative names:
Short chain dehydrogenase/reductase family 19C member 1
Alternative UPACC:
Q96LJ7; D3DS71; Q8NDG3; Q96B59; Q96CQ5
Background:
Dehydrogenase/reductase SDR family member 1, also known as Short chain dehydrogenase/reductase family 19C member 1, is a pivotal enzyme in the metabolism of steroids and xenobiotics. It functions as an NADPH-dependent oxidoreductase, facilitating the reduction of various substrates including estrone, androstene-3,17-dione, cortisone, prostaglandin E1, and isatin. This enzyme's activity underscores its essential role in the intricate biochemical pathways that modulate steroid levels and detoxify foreign substances.
Therapeutic significance:
Understanding the role of Dehydrogenase/reductase SDR family member 1 could open doors to potential therapeutic strategies. Its involvement in steroid and xenobiotic metabolism positions it as a key target for interventions aimed at modulating hormonal balances and enhancing the body's capacity to neutralize harmful compounds.